SEC Form 4 · accession 0001658613-17-000002
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
William Edward McKechnie
Director
Period of report
Sep 16, 2015
Accepted (ET)
Jun 2, 2017 · 7:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | May 31, 2017 | A | 35,249 | $0.34 | A | 288,626 | D | |
| Common Shares | holding | — | — | — | 253,377 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.17 | holding | — | — | — | Sep 16, 2015 | Sep 16, 2020 | Common Shares | 110,000 | 110,000 | D |